Resources
A double blind placebo controlled study demonstrated the efficacy and safety of
pentoson polysulphate for the relief of symptoms of interstitial cystitis
The treatment of interstitial cystitis (IC), a chronic inflammatory condition of
the bladder that can adversely affect quality of life. With the availability of
2 approved pharmacologic agents, the treatment of IC is less challenging and more
effective than it was in the past.
Interstitial cystitis: a retrospective analysis of treatment with pentosan polysulfate
and follow-up patient survey.
Combined therapy of intravesical and oral PPS medication is a safe and effective
therapeutic option for the treatment of moderate and severe cases of interstitial
cystitis.
A double-blind, placebo-controlled study demonstrated both efficacy and safety of
PPS for the relief of the symptoms of interstitial cystitis.Both patients and investigators
evaluated PPS as significantly more effective than placebo overall.
Focus on interstitial cystitis with case studies.
IC appears to be far more common than previously thought and is clearly misdiagnosed
and underdiagnosed.
Interstitial Cystitis: New Concepts in Pathogenesis, Diagnosis, and Management.
Interstitial cystitis previously considered a rare disorder, it is now known to
be a chronic, severely debilitating disease of the urinary bladder.
